Citigroup: The US decision to remove Pharmacogon from the 1260H list is a significant benefit for the stock and may boost market sentiment across the Chinese executive segment.

Zhitongcaijing · 6d ago
Citigroup: The US decision to remove Pharmacogon from the 1260H list is a significant benefit for the stock and may boost market sentiment across the Chinese executive segment.